Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer entities : Novartis ag save search
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.32%
H: 0.04%
C: -0.56%
ARVN | $33.96 -2.69% -2.77% 530K
|
Health Technology
|
| O: 8.28%
H: 0.56%
C: -4.75%
arv-766 protac license cancer treatment global protein for commercialization agreement
Radiopharmaceuticals Market to Reach $11.6 Billion by 2034 as Cancer Treatment Gains Traction - Future Market Insights, Inc.
Published: 2024-03-25 (Crawled : 15:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.08%
H: 0.15%
C: -0.44%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.06%
H: 0.96%
C: 0.26%
CAH | $103.37 0.53% 0.0% 2.5M
|
Distribution Services
|
| O: 0.02%
H: 0.73%
C: -0.02%
LNTH | $64.41 2.13% 2.08% 590K
|
Health Technology
|
| O: 0.1%
H: 1.98%
C: -0.08%
reach cancer treatment market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.26%
H: 1.36%
C: 1.36%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -0.85%
H: 1.12%
C: 0.43%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
UCBJY | $64.93 -4.38% 6.2K
|
Manufacturing
|
| O: 1.46%
H: 0.44%
C: 0.44%
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: -0.27%
H: 0.0%
C: -1.17%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -0.2%
H: 0.14%
C: -0.48%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.06%
H: 0.46%
C: 0.29%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.69%
H: 1.42%
C: 1.22%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 2.37%
H: 1.51%
C: 0.79%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: -0.65%
H: 1.63%
C: 1.48%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -0.88%
H: 1.46%
C: 1.13%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -2.81%
H: 2.08%
C: 1.38%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.35%
H: 1.15%
C: 0.96%
lung reach cancer cell diagnostics therapy market
9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published: 2024-02-19 (Crawled : 16:00) - prnewswire.com
BIIB | $193.18 -0.48% -0.48% 1.4M
|
Health Technology
| Email alert
Add to watchlist
VTRS | News A | $11.36 0.98% 0.97% 4.7M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 6.88% 490
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
| Email alert
Add to watchlist
JAZZ | $109.685 0.79% 0.78% 380K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
| Email alert
Add to watchlist
cancer cell global growth market
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200
|
Health Technology
|
| O: -1.53%
H: 0.0%
C: 0.0%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
UCBJY | $64.93 -4.38% 6.2K
|
Manufacturing
|
| O: 1.71%
H: 1.28%
C: 0.94%
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: 0.28%
H: 0.18%
C: 0.0%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.07%
H: 0.42%
C: 0.07%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.09%
H: 0.39%
C: -0.36%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 1.47%
H: 0.0%
C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.76%
H: 4.31%
C: 2.11%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: -0.14%
H: 0.35%
C: -1.12%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
VRTX | $404.93 1.25% 1.43% 1.1M
|
Health Technology
|
| O: 0.15%
H: 2.4%
C: 0.56%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
JAZZ | $109.685 0.79% 0.78% 380K
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: -1.4%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.4%
H: 0.19%
C: -0.33%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: -6.22%
report cancer blood growth market
United States Endometrial Cancer Research Report 2023
Published: 2024-02-02 (Crawled : 10:00) - prnewswire.com
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.21%
H: 0.49%
C: -0.9%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.5%
H: 0.26%
C: -1.03%
report cancer research
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 5.68%
H: 0.77%
C: 0.77%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 3.41%
H: 0.0%
C: -2.45%
VTRS | News A | $11.36 0.98% 0.97% 4.7M
|
Health Technology
|
| O: -0.08%
H: 3.47%
C: -0.25%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -2.04%
H: 0.19%
C: -1.97%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 4.04%
H: 1.57%
C: -3.02%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.5%
H: 0.07%
C: -0.81%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
PBYI | $5.12 -0.97% -0.98% 290K
|
Health Technology
|
| O: -0.1%
H: 2.31%
C: -1.26%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 0.82%
H: 0.12%
C: -1.64%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.44%
H: 0.2%
C: -0.55%
drug breast expected cancer pipeline therapeutics growth market
Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio
Published: 2024-01-09 (Crawled : 03:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: -3.88%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: -1.22%
H: 0.0%
C: -0.72%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.46%
H: 0.74%
C: -0.19%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.92%
H: 0.63%
C: -0.25%
america cancer treatment market
Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio
Published: 2024-01-04 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 2.46%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.49%
H: 0.6%
C: -0.83%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 0.15%
H: 1.88%
C: -1.17%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: -0.24%
H: 1.43%
C: 1.43%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.32%
H: 0.93%
C: 0.38%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.36%
H: 0.98%
C: 0.72%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.68%
H: 0.87%
C: 0.1%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.32%
H: 0.44%
C: 0.26%
america cancer immunotherapy market
Global Cancer Immunotherapy Market Poised to Exceed US$ 188 Billion by 2030, with CAGR of 10.02%
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -1.67%
H: 1.17%
C: 0.85%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 1.16%
H: 0.14%
C: -1.89%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.11%
H: 0.5%
C: -1.78%
cancer global immunotherapy market
US Kidney Cancer Therapeutics and Diagnostics Market to 2028, Featuring Profiles of Amgen, Hoffman-La Roche, Bayer, Pfizer, Bristol Myers Squibb and Novartis
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 1.56%
H: 0.51%
C: 0.51%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.45%
H: 0.75%
C: 0.46%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 1.83%
H: 0.04%
C: -1.13%
kidney cancer novartis diagnostics therapeutics market
Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 1.64%
H: 0.0%
C: -1.33%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 1.51%
H: 0.13%
C: -1.68%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.52%
H: 0.18%
C: -0.43%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.03%
H: 0.28%
C: -0.41%
BAX | $41.02 1.54% 0.0% 2.6M
|
Health Technology
|
| O: 0.14%
H: 0.78%
C: 0.22%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 0.73%
H: 0.06%
C: -1.38%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.2%
H: 0.2%
C: -0.76%
GOOGL | News S | $158.17 1.21% 1.19% 21M
|
Technology Services
|
| O: 1.97%
H: 0.0%
C: 0.0%
GOOG | News S | $159.82 1.18% 1.17% 16M
|
Technology Services
|
| O: 1.97%
H: 0.0%
C: 0.0%
ADBE A | $472.955 1.3% 1.28% 2.1M
|
Technology Services
|
| O: 0.97%
H: 0.08%
C: -2.03%
tube companies abbvie cancer pharmaceuticals therapeutics market
Novartis Pluvicto™ shows clinically meaningful and highly statistically significant rPFS benefit in patients with PSMA-positive metastatic castration-resistant prostate cancer in the pre-taxane setting
Published: 2023-10-23 (Crawled : 14:30) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.17%
H: 0.56%
C: 0.18%
cancer novartis
Novartis Kisqali® NATALEE analysis reinforces consistent reduction in risk of recurrence across key subgroups of patients with early breast cancer
Published: 2023-10-20 (Crawled : 10:00) - globenewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.42%
H: 0.16%
C: -1.32%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.6%
H: 0.61%
C: -0.56%
kisqali breast cancer risk novartis
North America Leads the Global Peptide Drug Conjugates Market Due to Increased Cancer Incidence
Published: 2023-10-20 (Crawled : 01:00) - prnewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.6%
H: 0.61%
C: -0.56%
america drug cancer global market
Global Next Generation Cancer Diagnostics Market Research Report 2023-2030: Key Players are Focusing on Innovative Product Launches and Geographical Expansion to Maintain their Competitive Edge
Published: 2023-10-06 (Crawled : 09:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: -0.52%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.95%
H: 0.41%
C: 0.08%
PHG | News | $21.01 1.94% 0.0% 2M
|
Health Technology
|
| O: -9.44%
H: 2.86%
C: 2.46%
A | $139.2 3.95% -0.14% 2M
|
Health Technology
|
| O: -1.81%
H: 2.08%
C: 1.05%
OPK | $1.245 1.22% 1.2% 2.4M
|
Health Technology
|
| O: -1.32%
H: 2.68%
C: 2.01%
MYGN | $18.595 0.57% 0.56% 510K
|
Health Technology
|
| O: -0.97%
H: 4.4%
C: -0.59%
ILMN | $124.41 3.46% 3.34% 1.3M
|
Health Technology
|
| O: -1.36%
H: 2.95%
C: 1.8%
report cancer expansion research global diagnostics market
Novartis to present new oncology data at ESMO 2023 demonstrating practice-changing innovation in advanced prostate and early breast cancer
Published: 2023-10-05 (Crawled : 06:00) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -1.21%
H: 1.3%
C: 1.16%
breast innovation cancer novartis
Sandoz receives positive CHMP opinion for breast and gastric cancer biosimilar trastuzumab
Published: 2023-09-18 (Crawled : 06:00) - globenewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: -1.31%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.06%
H: 0.09%
C: -0.6%
biosimilar chmp breast positive cancer
Global Next Generation Cancer Diagnostics Market Projected to Reach $57.8 Billion by 2030
Published: 2023-08-18 (Crawled : 00:20) - prnewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
| Email alert
Add to watchlist
reach cancer global diagnostics market
Prostate Cancer Global Market to Witness Upsurge in Growth at a CAGR of ~5% by 2028 | DelveInsight
Published: 2023-07-05 (Crawled : 21:00) - prnewswire.com
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: 0.86%
H: 0.0%
C: -1.01%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -1.17%
H: 0.63%
C: 0.22%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.55%
H: 0.97%
C: 0.02%
VERU | $1.27 0.0% 2.6M
|
Health Technology
|
| O: -0.83%
H: 0.0%
C: -6.72%
OPK | $1.245 1.22% 1.2% 2.4M
|
Health Technology
|
| O: -1.19%
H: 1.2%
C: -0.72%
ADXS | $0.572 12.48% 270
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -6.83%
cancer global growth market
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.